🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. logo
Market Cap: Highest
Employees: High

ONPATTRO

Alnylam Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. It targets genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and CNS/ocular diseases.

Tags: CNS diseases, RNAi therapeutics, biopharmaceutical, cardio-metabolic diseases, genetic medicines, hepatic diseases

Website

About | Leadership | DEI | About | About | About | About | About | About | Contact | Careers | Careers | Careers | Careers | Jobs | News | News | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Culture | Jobs | About | News | News | News | News | Careers | News | News | Careers | About | About | About | About | About | About | About | Jobs | About

Symbol: ALNY

Recent Price: $236.01

Industry: Biotechnology

CEO: Dr. Yvonne L. Greenstreet M.B.A., MBChB

Sector: Healthcare

Employees: 2100

Address: 675 West Kendall Street, Cambridge, MA 02142

Phone: 617 551 8200

Leadership

  • Yvonne Greenstreet, Chief Executive Officer
  • Pushkal Garg, Chief Medical Officer
  • Jeff Poulton, Chief Financial Officer
  • Kelley Boucher, Chief Human Resource Officer
  • Timothy Maines, Chief Technical Operations and Quality Officer
  • Tolga Tanguler, Chief Commercial Officer
  • Piyush Sharma, Chief Ethics & Compliance Officer
  • Evan Lippman, Chief Corporate Development & Strategy Officer
  • Kevin Fitzgerald, Chief Scientific Officer
  • Amy W. Schulman, Chair
  • Dennis A. Ausiello,
  • Carolyn Bertozzi,
  • Michael W. Bonney,
  • Olivier Brandicourt,
  • Margaret A. Hamburg,
  • Peter N. Kellogg,
  • David E.I. Pyott,
  • Colleen F. Reitan,
  • Phillip A. Sharp,
  • Elliott Sigal,

Last updated: 2024-12-31